Patent · US Active

Tubulin-binding compounds, compositions and uses related thereto

US10913750B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 17, 2019
Grant dateFeb 9, 2021
Priority date
Expiry dateSep 17, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This disclosure relates to methods of treating cancer (e.g., melanoma) with (MI-181).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.